opentargets-database

You identify therapeutic targets by querying the Open Targets Platform API to retrieve target-disease associations and evaluate the supporting genetic, clinical, and molecular evidence. This streamlines drug discovery research.

Gathering genetic and clinical evidence for drug repurposing involves querying integrated biomedical datasets through the Open Targets API to retrieve detailed drug information and existing target-disease links. This validates new drug indications.

Validating target-disease associations is best achieved by querying the Open Targets Platform to analyze integrated biological and clinical datasets, retrieving detailed evidence to assess druggability and safety for drug discovery.

Yes, you need programmatic access to query the Open Targets Platform GraphQL API. It requires the requests dependency to retrieve and analyze diverse biomedical data for pharmacology and target identification.

You can assess the druggability and safety of targets for Alzheimer's disease by searching associated genes via the Open Targets API, reviewing the strength of genetic evidence, and evaluating the retrieved drug information.